Thomas J. Lynch Jr. Bristol Myers Squibb CO (BMY) insider trading activity

BMY Quotes by TradingView

Thomas J. Lynch Jr. is EVP & Chief Scientific Officer of BRISTOL MYERS SQUIBB CO. Currently has a direct ownership of 22,222 shares of BMY, which is worth approximately $1.28 Million. The most recent transaction as insider was on Apr 03, 2019, when has been sold 6,171 shares (Common Stock, $0.10 par value) at a price of $46.88 per share, resulting in proceeds of $289,296. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.2K
0% 3M change
0% 12M change
Total Value Held $1.28 Million

Thomas J. Lynch Jr. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 03 2019
SELL
Payment of exercise price or tax liability
$289,296 $46.88 p/Share
6,171 Reduced 21.73%
22,222 Common Stock, $0.10 pa...
Apr 03 2019
SELL
Other acquisition or disposition
-
773 Reduced 2.99%
25,042 Common Stock, $0.10 pa...
Apr 03 2019
BUY
Exercise of conversion of derivative security
-
11,594 Added 30.99%
25,815 Common Stock, $0.10 pa...
Mar 10 2019
SELL
Other acquisition or disposition
-
1,387 Reduced 6.5%
19,955 Common Stock, $0.10 pa...
Mar 10 2019
SELL
Payment of exercise price or tax liability
$122,462 $51.39 p/Share
2,383 Reduced 11.94%
17,572 Common Stock, $0.10 pa...
Mar 10 2019
BUY
Exercise of conversion of derivative security
-
5,864 Added 21.55%
21,342 Common Stock, $0.10 pa...
Apr 03 2018
SELL
Payment of exercise price or tax liability
$444,914 $62.77 p/Share
7,088 Reduced 31.41%
15,478 Common Stock, $0.10 pa...
Apr 03 2018
BUY
Exercise of conversion of derivative security
-
12,367 Added 40.37%
18,266 Common Stock, $0.10 pa...
Apr 03 2018
BUY
Other acquisition or disposition
-
949 Added 4.71%
19,215 Common Stock, $0.10 pa...
Dec 12 2017
SELL
Open market or private sale
$335,172 $63.24 p/Share
5,300 Reduced 36.43%
9,250 Common Stock, $0.10 pa...
May 14 2017
BUY
Exercise of conversion of derivative security
-
14,550 Added 50.0%
14,550 Common Stock, $0.10 pa...

Also insider at

FHTX
Foghorn Therapeutics Inc. Healthcare
TJL

Thomas J. Lynch Jr.

EVP & Chief Scientific Officer
New York, NY

Track Institutional and Insider Activities on BMY

Follow BRISTOL MYERS SQUIBB CO and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BMY shares.

Notify only if

Insider Trading

Get notified when an Bristol Myers Squibb CO insider buys or sells BMY shares.

Notify only if

News

Receive news related to BRISTOL MYERS SQUIBB CO

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BMY